Tarini Mohapatra: Founder of TFives on How Evidence-First Architecture Gets Life-Sciences AI Through Regulatory Gates
A path-breaking adverse drug reaction prediction model with roughly 85% accuracy was shelved after 18 months. Not because…
Browsing Tag